This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Major coronary heart disease event excluding revascularizations
DOID EFO MESH Endpoint Browser
I9_CHD_NOREV
intermediate coronary syndrome: Precordial pain at rest, which may precede a MYOCARDIAL INFARCTION.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Check only main diagnosis
Yes, side diagnoses are not checked
Hospital discharge: ICD-9
410|4110
Hospital discharge: ICD-8
410|4110
Cause of death: ICD-9
41[0-4]|798
Cause of death: ICD-8
41[0-4]|798
Cause of death: excluded ICD-9
7980A
2 out of 7 registries used, show all original rules.
40671
Check minimum number of events None
40671
Remove individuals based on genotype QC
39379
I9_CHD_NOREV
Control definitions
Control exclude
I9_CHD
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Major coronary heart disease event excluding revascularizations
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 39379 | 11352 | 28027 |
| Unadjusted prevalence (%) | 9.56 | 4.93 | 15.42 |
| Mean age at first event (years) | 66.92 | 69.01 | 66.07 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: I9_CHD_NOREV – Major coronary heart disease event excluding revascularizations
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Major coronary heart disease event excluding revascularizations
↥Endpoint not on priority list, no data to show.